Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 283 publications
Neoadjuvant intraprostatic immunotherapy for high-risk localized prostate cancer.
Journal: Nature reviews. Urology
Published: June 04, 2026
Genomic Features and Response to Poly(ADP-ribose) Polymerase Inhibition in Metastatic Castration-Resistant Prostate Cancer.
Journal: JCO precision oncology
Published: March 18, 2026
ARAMON, a phase 2 open-label trial of darolutamide monotherapy in patients with biochemical recurrence or oligometastatic castration-sensitive prostate cancer after radical prostatectomy or primary radiotherapy.
Journal: European urology focus
Published: February 27, 2026
Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 26, 2026
Reprogramming of TLR-Ferroptosis Signaling and Immunometabolic Pathways Overcomes Myeloid Suppression to Improve Checkpoint Blockade in Prostate Cancer.
Journal: Cancer research
Published: October 30, 2025
Apalutamide + Abiraterone Acetate plus Prednisone + Leuprolide with Stereotactic, Ultra-Hypofractionated Radiation in Very High-Risk Prostate Cancer: A Single-Arm, Phase 2 Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 27, 2025
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression.
Journal: Cancer cell
Published: October 25, 2025
A phase 1b/2 study of intermittent talazoparib plus temozolomide in patients with metastatic castration-resistant prostate cancer and no mutations in DNA damage response genes.
Journal: Investigational new drugs
Published: August 11, 2025
Anti-tumour effects of perioperative ketamine in lung cancer: a non-randomised, exploratory biomarker study.
Journal: British journal of anaesthesia
Published: July 30, 2025
Accelerating Drug Development in Hormone-Naïve Prostate Cancer through Multimodal Therapy Strategies: The MetaCURE Phase 2 Randomized Clinical Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 25, 2025
Two Decades of Disease Evolution and Biomarker-Guided Clinical Decision Making in Metastatic Prostate Cancer.
Journal: International journal of molecular sciences
Published: July 10, 2025
Genomic alterations in the YAP/TAZ pathway are associated with stem cell-like castration-resistant prostate cancer.
Journal: medRxiv : the preprint server for health sciences
Published: July 09, 2025
Last Updated: 09/26/2026